REGENXBIO Announces Equity Offering for $100 Million
REGENXBIO (RGNX) announced a public equity offering of approximately 10 million common shares and 1.11 million pre-funded warrants, expected to raise around $100 million in gross proceeds before fees and expenses.
Tickers: $RGNX